WallStreetZenWallStreetZen

NASDAQ: BCRX
Biocryst Pharmaceuticals Inc Stock Ownership - Who owns Biocryst Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biocryst Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alane P. BarnesChief Legal Officer2025-12-2221,773$7.65
$166.56kSell
Charles K. GayerPresident and CCO2025-12-2210,091$5.04
$50.86kBuy
Charles K. GayerPresident and CCO2025-12-2214,142$3.22
$45.54kBuy
Charles K. GayerPresident and CCO2025-12-2250,000$5.51
$275.50kBuy
Charles K. GayerPresident and CCO2025-12-1911,477$7.41
$85.04kSell
Alane P. BarnesChief Legal Officer2025-12-1916,902$7.41
$125.24kSell
Jon P. StonehouseChief Executive Officer2025-12-1961,793$7.41
$457.89kSell
Alane P. BarnesChief Legal Officer2025-12-1521,210$7.65
$162.26kSell
Alane P. BarnesChief Legal Officer2025-12-128,540$7.57
$64.65kSell
Jon P. StonehouseChief Executive Officer2025-12-1227,368$7.57
$207.18kSell

1 of 3

BCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCRX insiders and whales buy or sell their stock.

BCRX Shareholders

What type of owners hold Biocryst Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc10.35%21,790,881$147.31MInstitution
Baker Bros Advisors LP10.23%21,543,334$145.63MInsider
Blackrock Inc10.09%21,245,876$143.62MInstitution
Deerfield Management Company LP5.78%12,169,000$82.26MInstitution
State Street Corp4.66%9,807,438$66.30MInstitution
Kynam Capital Management LP4.46%9,390,270$63.48MInstitution
Ubs Group Ag2.83%5,967,737$40.34MInstitution
Alkeon Capital Management LLC2.60%5,464,021$36.94MInstitution
Arrowstreet Capital Limited Partnership2.48%5,225,986$35.33MInstitution
Morgan Stanley2.47%5,202,959$35.17MInstitution

1 of 3

BCRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCRX83.58%16.42%Net SellingNet Selling
PHAR0.01%0.00%
ATAI12.02%25.40%Net Buying
KOD66.62%33.38%Net BuyingNet Buying
GLUE33.20%66.80%Net SellingNet Selling
View Top Biotech Stocks

Biocryst Pharmaceuticals Stock Ownership FAQ

Who owns Biocryst Pharmaceuticals?

Biocryst Pharmaceuticals (NASDAQ: BCRX) is owned by 92.21% institutional shareholders, 18.12% Biocryst Pharmaceuticals insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Biocryst Pharmaceuticals shareholder, owning 21.54M shares representing 10.23% of the company. Baker Bros Advisors LP's Biocryst Pharmaceuticals shares are currently valued at $143.48M.

If you're new to stock investing, here's how to buy Biocryst Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.